Literature DB >> 17075523

[Nerve excitability studies in the assessment of dysimmune neuropathies].

J-P Lefaucheur1, D Boërio, J-Y Hogrel, A Créange.   

Abstract

INTRODUCTION: Various changes in axonal membrane excitability might explain negative symptoms in dysimmune neuropathies, e.g., acute or chronic inflammatory demyelinating neuropathies or multifocal neuropathies with persistent conduction blocks. Several electrophysiological methods have recently been designed to specifically assess such axonal membrane excitability changes. STATE OF ART: Resting and action potentials are related to ionic movements through the axonal membrane, mainly involving various types of sodium and potassium channels, as well as the ATP-dependent Na+/K+ pump. The functional status of these channels and pumps can be assessed in man, by studying the excitability recovery cycle after a single impulse, the strength-duration and stimulus-response curves, and the effects of hyperpolarization and depolarization depending on activity (voluntary contraction), ischemia or application of prolonged subthreshold currents. Various features of altered axonal membrane excitability might characterize dysimmune neuropathies, according to the course of the disease and its treatment. PERSPECTIVES: This electrophysiological approach allowed changes in axonal membrane properties to be objectively determined. In particular, some results obtained with these methods could explain the rapid action of intravenous immunoglobulins, and various pathophysiological mechanisms of conduction block or axonal degeneration.
CONCLUSIONS: Nerve excitability studies appeared to be useful for the diagnosis and the follow-up of dysimmune neuropathies. New therapeutical strategies for such neuropathies will be probably developed in the future intending to improve nerve function by acting on axonal membrane excitability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17075523

Source DB:  PubMed          Journal:  Rev Neurol (Paris)        ISSN: 0035-3787            Impact factor:   2.607


  2 in total

1.  Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir.

Authors:  Romain Coriat; Jérôme Alexandre; Carole Nicco; Laurent Quinquis; Evelyne Benoit; Christiane Chéreau; Hervé Lemaréchal; Olivier Mir; Didier Borderie; Jean-Marc Tréluyer; Bernard Weill; Joel Coste; François Goldwasser; Frédéric Batteux
Journal:  J Clin Invest       Date:  2013-12-20       Impact factor: 14.808

2.  Toxic c17-sphinganine analogue mycotoxin, contaminating tunisian mussels, causes flaccid paralysis in rodents.

Authors:  Riadh Marrouchi; Evelyne Benoit; Jean-Pierre Le Caer; Nawel Belayouni; Hafedh Belghith; Jordi Molgó; Riadh Kharrat
Journal:  Mar Drugs       Date:  2013-11-28       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.